ANTIRETROVIRAL TOXICITY AND OXIDATIVE STRESS
Authors:
- Oru-Bo Precious GeoffreyOGOru-Bo Precious Geoffrey
Open Access
- 1 April 2013
- journal article
- Published by Science Publications in American Journal of Pharmacology and Toxicology
- Vol. 8 (4) , 187-196
Abstract
ANTIRETROVIRAL TOXICITY AND OXIDATIVE STRESSKeywords
This publication has 72 references indexed in Scilit:
- Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trialsThe Lancet, 2010
- Raltegravir: a new choice in HIV and new chances for researchThe Lancet, 2009
- Enhanced killing of chemo-resistant breast cancer cells via controlled aggravation of ER stressCancer Letters, 2009
- HIV-1 antiretrovirals induce oxidant injury and increase intima–media thickness in an atherogenic mouse modelToxicology Letters, 2009
- Changes in antioxidant profile among HIV-infected individuals on generic highly active antiretroviral therapy in southern IndiaInternational Journal of Infectious Diseases, 2008
- The role of protease inhibitors in the pathogenesis of HIV-associated insulin resistance: Cellular mechanisms and clinical implicationsCurrent HIV/AIDS Reports, 2007
- Protective effect of acetyl‐l‐carnitine against oxidative stress induced by antiretroviral drugsFEBS Letters, 2006
- Free radicals, metals and antioxidants in oxidative stress-induced cancerChemico-Biological Interactions, 2006
- Indinavir impairs endothelial function in healthy HIV-negative menAmerican Heart Journal, 2005
- Mitochondrial dysfunction and nucleoside reverse transcriptase inhibitor therapy: experimental clarifications and persistent clinical questionsAntiviral Research, 2003